Sekisui Expands Point-of-Care Diagnostics Offering
The company is now the exclusive distributor of a fully automated, quantitative immunoassay-based system that generates immunoassay results in 12 minutes or less.
Read More
Search Results for: liver disease
Inside Track: A Fresh Look at Colorectal Cancer
David A. Ahlquist, MD, coinventor of the Cologuard stool-based DNA screening test for colorectal cancer, discusses updated USPSTF guidelines that seek to increase screening rates.
Read More
Investors Back Disease Breathalyzer
Owlstone Medical Ltd, Cambridge, UK, has been spun out of parent company Owlstone Inc to develop and commercialize a breathalyzer for use in clinical diagnostics and precision medicine, with applications in cancer, and inflammatory and infectious disease.
Read MoreStaggering Statistics on Scope of STD Problem
More than half of all people will have an STI or STD at some point in their lifetime, and recent estimates from the Centers for Disease Control and Prevention show that there are 19.7 million new STIs every year in the United States.
Read More
Module Designed to Meet Demand for Increased Diagnostic Testing
The Cobas e 801 module is a dedicated, high-volume immunoassay system now available for countries accepting the CE mark.
Read More